Woman and Man
- | Country :
- France
- | organs : -
- | Specialty : -
Extract
This Phase II study will test whether CYR-101, a CNS-active compound with novel pharmacological profile and devoid of dopamine D2 receptor binding properties, is efficacious when administered orally in the management of patients with a diagnosis of DSM-IV schizophrenia.
Inclusion criteria
- Schizophrenia